[go: up one dir, main page]

MA54714A - Formulation de nicotine - Google Patents

Formulation de nicotine

Info

Publication number
MA54714A
MA54714A MA054714A MA54714A MA54714A MA 54714 A MA54714 A MA 54714A MA 054714 A MA054714 A MA 054714A MA 54714 A MA54714 A MA 54714A MA 54714 A MA54714 A MA 54714A
Authority
MA
Morocco
Prior art keywords
nicotine formulation
nicotine
formulation
Prior art date
Application number
MA054714A
Other languages
English (en)
Inventor
Joseph Kavanagh
Christopher Nolan
Brian O'rourke
Kieran Raleigh
Original Assignee
Yatzz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yatzz Ltd filed Critical Yatzz Ltd
Publication of MA54714A publication Critical patent/MA54714A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0085Inhalators using ultrasonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/06Inhaling appliances shaped like cigars, cigarettes or pipes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Manufacture Of Tobacco Products (AREA)
MA054714A 2018-06-01 2019-05-31 Formulation de nicotine MA54714A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18175640.4A EP3574902A1 (fr) 2018-06-01 2018-06-01 Formulation de nicotine et mode d'administration

Publications (1)

Publication Number Publication Date
MA54714A true MA54714A (fr) 2021-11-17

Family

ID=62528283

Family Applications (2)

Application Number Title Priority Date Filing Date
MA054714A MA54714A (fr) 2018-06-01 2019-05-31 Formulation de nicotine
MA50205A MA50205B1 (fr) 2018-06-01 2019-05-31 Formulation de nicotine

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA50205A MA50205B1 (fr) 2018-06-01 2019-05-31 Formulation de nicotine

Country Status (13)

Country Link
US (2) US11833145B2 (fr)
EP (3) EP3574902A1 (fr)
JP (1) JP7224375B2 (fr)
CN (1) CN112218637A (fr)
AU (2) AU2019276357B2 (fr)
BR (1) BR112020024088B1 (fr)
CA (1) CA3099940A1 (fr)
ES (1) ES2883799T3 (fr)
MA (2) MA54714A (fr)
MX (1) MX2020012810A (fr)
PL (1) PL3684362T3 (fr)
SG (1) SG11202011761XA (fr)
WO (1) WO2019229249A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3574902A1 (fr) * 2018-06-01 2019-12-04 Yatzz Limited Formulation de nicotine et mode d'administration
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817867D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817868D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
GB201817860D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
GB201817865D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
KR20210108390A (ko) * 2018-12-31 2021-09-02 필립모리스 프로덕츠 에스.에이. 저점도 액체 니코틴 제형
EP3905908B1 (fr) 2019-06-20 2025-01-08 Shaheen Innovations Holding Limited Dispositif d'atomisation à ultrasons personnel
FR3102041B1 (fr) * 2019-10-22 2025-02-14 Aroma Sens Edulcorant pour liquides de cigarette électronique
JP7578712B2 (ja) 2019-12-15 2024-11-06 シャヒーン イノベーションズ ホールディング リミテッド 超音波ミスト吸入器
US11666713B2 (en) 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
US12121056B2 (en) 2019-12-15 2024-10-22 Shaheen Innovations Holding Limited Hookah device
ES2982684T3 (es) 2019-12-15 2024-10-17 Shaheen Innovations Holding Ltd Inhalador de nebulización ultrasónico
EP3855949A1 (fr) 2019-12-15 2021-08-04 Shaheen Innovations Holding Limited Inhalateur de brume ultrasonore
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US12201144B2 (en) 2019-12-15 2025-01-21 Shaheen Innovations Holding Limited Hookah device
KR102725481B1 (ko) 2019-12-15 2024-11-06 샤힌 이노베이션즈 홀딩 리미티드 초음파 미스트 흡입장치
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
AU2020410172B2 (en) 2019-12-15 2023-02-23 Shaheen Innovations Holding Limited Mist inhaler devices
EP4076025A1 (fr) * 2019-12-18 2022-10-26 Philip Morris Products, S.A. Formulation destinée à être utilisée dans un système de génération d'aérosol
JP7609561B2 (ja) * 2020-02-05 2025-01-07 日本たばこ産業株式会社 液体加熱式の加熱型香味吸引器用の液体組成物
CA3172852A1 (fr) 2020-03-27 2021-09-30 Mcneil Ab Cartouche contenant de la nicotine
MA65146B1 (fr) * 2020-04-06 2024-05-31 Shaheen Innovations Holding Ltd Dispositifs d'inhalateur de brouillard
CN111802686A (zh) * 2020-07-27 2020-10-23 湖北中烟工业有限责任公司 含脂肪酸、植物油的雾化剂以及加热不燃烧卷烟
CN111855866A (zh) * 2020-08-25 2020-10-30 甘肃烟草工业有限责任公司 一种快速测定烟用添加剂中甲醛的方法
IL303786B2 (en) * 2020-12-15 2024-07-01 Shaheen Innovations Holding Ltd Mist inhaler devices
CN113197330A (zh) * 2021-04-28 2021-08-03 深圳市博睿生物科技有限公司 一种电子烟新型甜味剂及制备方法及应用
IL283002A (en) * 2021-05-06 2022-12-01 Nicogen Ltd Nicotine formulations and aerosols
CN113912585B (zh) * 2021-11-09 2023-02-24 深圳萨特瓦生物科技有限公司 复合尼古丁盐及其制备方法与应用、电子烟油及电子烟
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves
CN116019250B (zh) * 2022-12-22 2025-02-14 东莞市吉纯生物技术有限公司 基于酸性电解水的雾化液、制备方法和酸性电解水制备方法
WO2024138377A1 (fr) * 2022-12-27 2024-07-04 思摩尔国际控股有限公司 Liquide d'atomisation, atomiseur et dispositif d'atomisation électronique
WO2024161313A1 (fr) * 2023-01-31 2024-08-08 Rai Strategic Holdings, Inc. Formulations de précurseur d'aérosol stabilisées
CN118787123A (zh) * 2023-04-14 2024-10-18 思摩尔国际控股有限公司 一种水基电子烟雾化制剂及其制备方法和应用
CN117898466B (zh) * 2024-02-29 2024-09-24 深圳市艾斯摩迪斯科技有限公司 一种复合尼古丁盐的制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
CA2231968A1 (fr) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Methode de production d'un medicament a base de nicotine
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
GB0712308D0 (en) * 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition
CN114223927A (zh) * 2013-05-06 2022-03-25 尤尔实验室有限公司 用于气溶胶装置的烟碱盐调配物及其方法
UA122320C2 (uk) * 2013-07-19 2020-10-26 Олтріа Клайєнт Сервісиз Ллк Рідка аерозольна композиція для електронного курильного виробу
DE102015117811A1 (de) * 2015-10-20 2017-04-20 Chv Pharma Gmbh & Co. Kg Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator
EP3574902A1 (fr) * 2018-06-01 2019-12-04 Yatzz Limited Formulation de nicotine et mode d'administration

Also Published As

Publication number Publication date
EP3574902A1 (fr) 2019-12-04
MA50205B1 (fr) 2021-09-30
AU2019276357B2 (en) 2023-04-20
MX2020012810A (es) 2022-03-08
NZ769793A (en) 2024-05-31
BR112020024088B1 (pt) 2022-10-11
EP3684362A1 (fr) 2020-07-29
WO2019229249A1 (fr) 2019-12-05
JP7224375B2 (ja) 2023-02-17
PL3684362T3 (pl) 2021-12-20
EP3684362B1 (fr) 2021-06-23
ES2883799T3 (es) 2021-12-09
AU2023202855A1 (en) 2023-05-25
BR112020024088A2 (pt) 2021-02-17
US20210196700A1 (en) 2021-07-01
EP3909581A1 (fr) 2021-11-17
JP2021526147A (ja) 2021-09-30
CA3099940A1 (fr) 2019-12-05
AU2023202855B2 (en) 2024-08-22
US11833145B2 (en) 2023-12-05
MA50205A (fr) 2020-07-29
SG11202011761XA (en) 2020-12-30
AU2019276357A1 (en) 2020-11-26
CN112218637A (zh) 2021-01-12
US20240050424A1 (en) 2024-02-15

Similar Documents

Publication Publication Date Title
MA54714A (fr) Formulation de nicotine
DK3688162T3 (da) Formuleringer
EP3818843A4 (fr) Cigarette
MA50657A (fr) Formulations de niraparib
EP3818840A4 (fr) Cigarette
PL3703518T3 (pl) Formulacja ulegająca aerozolowaniu
DK3651736T3 (da) Langtidsvirkende formuleringer
DK3768669T3 (da) Piperazinazaspiroderivater
EP3905900C0 (fr) Formulation de nicotine liquide
EP3454847A4 (fr) Formulations de médicaments améliorées
MA50068A (fr) Formulations de copanlisib
HUE061610T2 (hu) Készítmény
EP3697418A4 (fr) Formulations de bromocriptine améliorées
PT3796975T (pt) Derivados de sulfonilaminobenzamida
EP4007576A4 (fr) Formulation antiarythmique
CL2018002038S1 (es) Cultivador
LT3790612T (lt) Inhaliatorius
IT201700095717A1 (it) Composizione erbicida
EP3471546A4 (fr) Formulation insecticide
EP3836980C0 (fr) Formulation
EP3768322C0 (fr) Formulation
ES1220991Y (es) Ahumador
UA39310S (uk) Культиватор
UA39308S (uk) Культиватор
UA39334S (uk) Культиватор